Quantcast
Channel: BioTuesdays » cancer detection
Browsing latest articles
Browse All 11 View Live

Verisante provides update on MSI system for skin cancer detection

Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has provided an update on its website regarding the development of its rapid multispectral imaging (MSI) system for skin cancer detection. The MSI device...

View Article



Image may be NSFW.
Clik here to view.

In conversation with James Howard-Tripp

James Howard-Tripp As executive chairman of GeneNews (TSX:GEN; OTC:GNWSF), James Howard-Tripp is a veteran of pharma and biotech management and company creation, which included a long stint as CEO of...

View Article

Verisante expands its sales and marketing team

Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has hired Jason Mangler as director of sales to guide the company’s worldwide sales and marketing strategy and also hired Kim Ellis as its sales...

View Article

Image may be NSFW.
Clik here to view.

Verisante receives Chinese patent for endoscopy imaging

The Chinese Patent Office has granted Verisante Technology’s (OTCQX:VRSEF; TSX-V:VRS) patent application entitled, “Methods and Apparatus for Measuring Cancerous Changes from Reflectance Spectral...

View Article

Image may be NSFW.
Clik here to view.

Verisante completes Core prototype

Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has completed the development of the Core series commercial prototype to aid in the detection of lung cancer. The Core system, which is based on the same...

View Article


Image may be NSFW.
Clik here to view.

Verisante receives F&S technology innovation award

Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has received the Frost & Sullivan 2014 North American Technology Innovation Leadership of the Year Award for In Vivo Cancer Detection for its skin...

View Article

Image may be NSFW.
Clik here to view.

Verisante in preliminary license agreement for upper GI cancer detection...

Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has signed a letter of intent with Astoria Capital SA, to sublicense and, in turn, finance the development and commercialization of Verisante’s cancer...

View Article

Image may be NSFW.
Clik here to view.

Verisante displays Aura at BC Cancer Foundation


Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) is partnering with the BC Cancer Foundation to showcase Verisante Aura, a device for the rapid detection of skin cancer. Aura “We are very appreciative of...

View Article


Image may be NSFW.
Clik here to view.

Verisante in sales pact for Core device in China

Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has closed a $300,000 private placement in conjunction with signing a letter of intent with a strategic partner for the exclusive marketing and sales...

View Article


Image may be NSFW.
Clik here to view.

Verisante begins FDA approval process for Aura

Verisante Technology (OTCQX:VRSEF; TSX-V:VRS) has initiated communications with the FDA for the approval of Aura, a device for the detection of skin cancer. “Verisante has now submitted documents to...

View Article
Browsing latest articles
Browse All 11 View Live




Latest Images